These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6428216)

  • 1. Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    McNeill WF; John JF; Twitty JA
    Am J Clin Pathol; 1984 Jun; 81(6):742-7. PubMed ID: 6428216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Hurley JC; Miller GH; Smith AL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):331-6. PubMed ID: 8582138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates.
    Kettner M; Milosovic P; Hletková M; Kallová J
    Infection; 1995; 23(6):380-3. PubMed ID: 8655211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD; Draus LL; Pasieczinik KA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of gentamicin resistance in nosocomial infections.
    John JF; Rubens CE; Farrar WE
    Am J Med Sci; 1980; 279(1):25-30. PubMed ID: 6768292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level resistance to gentamicin in clinical isolates of enterococci.
    Mederski-Samoraj BD; Murray BE
    J Infect Dis; 1983 Apr; 147(4):751-7. PubMed ID: 6404994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
    Clark RB; Sanders CC; Pakiz CB; Hostetter MK
    Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in Gene
    Bolard A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Ronco E; Vacheron F; Orabona A
    Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
    Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.